PL2491005T3 - Zastosowanie 4-[etylo(dimetylo)amonio]butanianu do leczenia chorób układu krążenia - Google Patents
Zastosowanie 4-[etylo(dimetylo)amonio]butanianu do leczenia chorób układu krążeniaInfo
- Publication number
- PL2491005T3 PL2491005T3 PL10773886T PL10773886T PL2491005T3 PL 2491005 T3 PL2491005 T3 PL 2491005T3 PL 10773886 T PL10773886 T PL 10773886T PL 10773886 T PL10773886 T PL 10773886T PL 2491005 T3 PL2491005 T3 PL 2491005T3
- Authority
- PL
- Poland
- Prior art keywords
- ammonio
- butanoate
- dimethyl
- ethyl
- treatment
- Prior art date
Links
- ISMYCKWHOZKHNJ-UHFFFAOYSA-N 4-[ethyl(dimethyl)azaniumyl]butanoate Chemical compound CC[N+](C)(C)CCCC([O-])=O ISMYCKWHOZKHNJ-UHFFFAOYSA-N 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LVP-09-181A LV14345B (lv) | 2009-10-22 | 2009-10-22 | 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai |
| EP10773886.6A EP2491005B1 (en) | 2009-10-22 | 2010-10-22 | Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease |
| PCT/EP2010/065924 WO2011048201A1 (en) | 2009-10-22 | 2010-10-22 | Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2491005T3 true PL2491005T3 (pl) | 2015-03-31 |
Family
ID=43530044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10773886T PL2491005T3 (pl) | 2009-10-22 | 2010-10-22 | Zastosowanie 4-[etylo(dimetylo)amonio]butanianu do leczenia chorób układu krążenia |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US9278907B2 (pl) |
| EP (1) | EP2491005B1 (pl) |
| JP (1) | JP5552169B2 (pl) |
| KR (1) | KR101355417B1 (pl) |
| CN (1) | CN102666476B (pl) |
| AR (1) | AR081514A1 (pl) |
| AU (1) | AU2010309756B2 (pl) |
| BR (1) | BR112012009162B8 (pl) |
| CA (1) | CA2781499C (pl) |
| CL (1) | CL2012001010A1 (pl) |
| CO (1) | CO6531459A2 (pl) |
| CU (1) | CU20120065A7 (pl) |
| DK (1) | DK2491005T3 (pl) |
| EA (1) | EA020303B1 (pl) |
| ES (1) | ES2508117T3 (pl) |
| GE (1) | GEP20146123B (pl) |
| HR (1) | HRP20140964T1 (pl) |
| IL (1) | IL219217A0 (pl) |
| LV (1) | LV14345B (pl) |
| ME (1) | ME01917B (pl) |
| MX (1) | MX2012004630A (pl) |
| NZ (1) | NZ599521A (pl) |
| PE (1) | PE20121473A1 (pl) |
| PL (1) | PL2491005T3 (pl) |
| PT (1) | PT2491005E (pl) |
| RS (1) | RS53620B1 (pl) |
| SI (1) | SI2491005T1 (pl) |
| SM (1) | SMT201400176B (pl) |
| TN (1) | TN2012000174A1 (pl) |
| UA (1) | UA107201C2 (pl) |
| WO (1) | WO2011048201A1 (pl) |
| ZA (1) | ZA201202916B (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8565150B2 (en) * | 2009-03-11 | 2013-10-22 | At&T Mobility Ii Llc | Architectural model for LTE (long term evolution) EPC (evolved packet core) deployment |
| MX351765B (es) * | 2011-04-27 | 2017-10-26 | Grindeks Jsc | Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares. |
| DE102012109911A1 (de) | 2011-10-19 | 2013-04-25 | Electronics And Telecommunications Research Institute | Energy harvesting device using electromagnetic interference signal and sensor system including the same |
| JO3117B1 (ar) * | 2012-12-20 | 2017-09-20 | Grindeks Jsc | استعمال 3- كربوكسي- ن-إيثيل- ن، ن- ثاني ميثيل بروبان-1– أمينيوم أو ملح منه مقبول صيدلانياً في معالجة تصلب الشرايين |
| JO3333B1 (ar) * | 2013-09-26 | 2019-03-13 | Grindeks Jsc | استعمال 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium أو ملح مقبول دوائيا منه للوقاية من السكري وعلاجه |
| CN107879944B (zh) * | 2017-10-30 | 2020-05-22 | 杭州海尔希畜牧科技有限公司 | 一种制备丁基甜菜碱的方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1238868A (pl) | 1967-08-08 | 1971-07-14 | ||
| SU997646A1 (ru) | 1978-11-27 | 1983-02-23 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср | Кормова добавка |
| IT1210935B (it) | 1981-09-17 | 1989-09-29 | Inst Orch Sinteza Akademi Nauk | Composizione farmaceutica per il trattamento di malattie cardiovascolari. |
| IT1190280B (it) * | 1986-04-24 | 1988-02-16 | Sigma Tau Ind Farmaceuti | Procedimento per la preparazione di gamma-butirrobetaina |
| US4933103A (en) * | 1987-03-23 | 1990-06-12 | Kao Corporation | Bleaching composition |
| SU1680693A1 (ru) * | 1987-03-25 | 1991-09-30 | Институт Органического Синтеза Ан Латвсср | Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность |
| JPH0291049A (ja) * | 1988-09-21 | 1990-03-30 | Lonza Ag | ｒ―ブチロベタインの製造方法 |
| JP3119430B2 (ja) * | 1995-07-25 | 2000-12-18 | 大鵬薬品工業株式会社 | 水酸基ラジカル消去剤 |
| LV11728B (en) * | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
| US5973026A (en) | 1998-02-02 | 1999-10-26 | Xerox Corporation | Ink jet inks |
| JP2000239239A (ja) * | 1999-02-22 | 2000-09-05 | Kankyo Meneki Gijutsu Kenkyusho:Kk | クロルメコート類縁化合物のハプテン化合物、抗体及び測定方法 |
| CA2508094A1 (en) | 2005-05-20 | 2006-11-20 | Vivier Canada Inc. | Composition for accelerating collagen synthesis |
| US7863274B2 (en) | 2005-07-29 | 2011-01-04 | Concert Pharmaceuticals Inc. | Deuterium enriched analogues of tadalafil as PDE5 inhibitors |
| LV13705B (en) | 2006-11-06 | 2008-07-20 | Ivars Kalvins | Process for producing high purity intermolecular salt of 3-carboxy-n,n,n-trimethyl-propane-1-amine hydroxide |
| JP4761265B2 (ja) | 2007-10-17 | 2011-08-31 | 学校法人甲南学園 | 核酸合成を促進する化合物を含む組成物およびその利用、並びに当該化合物の製造方法 |
| CN101538214A (zh) * | 2009-04-24 | 2009-09-23 | 潍坊祥维斯化学品有限公司 | 生产γ-丁基甜菜碱及其盐酸盐的方法 |
| EA201301079A1 (ru) * | 2011-04-27 | 2014-02-28 | Гриндекс, Джоинт Сток Кампани | 4-[(галоидалкил)(диметил)аммоний]бутаноаты и их применение при лечении сердечно-сосудистого заболевания |
-
2009
- 2009-10-22 LV LVP-09-181A patent/LV14345B/lv unknown
-
2010
- 2010-10-22 BR BR112012009162A patent/BR112012009162B8/pt active IP Right Grant
- 2010-10-22 CA CA2781499A patent/CA2781499C/en active Active
- 2010-10-22 EP EP10773886.6A patent/EP2491005B1/en active Active
- 2010-10-22 PE PE2012000523A patent/PE20121473A1/es active IP Right Grant
- 2010-10-22 RS RS20140547A patent/RS53620B1/sr unknown
- 2010-10-22 AR ARP100103859A patent/AR081514A1/es active IP Right Grant
- 2010-10-22 NZ NZ599521A patent/NZ599521A/xx unknown
- 2010-10-22 EA EA201200514A patent/EA020303B1/ru unknown
- 2010-10-22 ES ES10773886.6T patent/ES2508117T3/es active Active
- 2010-10-22 US US13/503,144 patent/US9278907B2/en active Active
- 2010-10-22 WO PCT/EP2010/065924 patent/WO2011048201A1/en not_active Ceased
- 2010-10-22 AU AU2010309756A patent/AU2010309756B2/en active Active
- 2010-10-22 UA UAA201204970A patent/UA107201C2/ru unknown
- 2010-10-22 SI SI201030752T patent/SI2491005T1/sl unknown
- 2010-10-22 JP JP2012534709A patent/JP5552169B2/ja active Active
- 2010-10-22 MX MX2012004630A patent/MX2012004630A/es active IP Right Grant
- 2010-10-22 DK DK10773886.6T patent/DK2491005T3/da active
- 2010-10-22 CN CN201080047660.5A patent/CN102666476B/zh active Active
- 2010-10-22 ME MEP-2014-131A patent/ME01917B/me unknown
- 2010-10-22 PT PT107738866T patent/PT2491005E/pt unknown
- 2010-10-22 HR HRP20140964AT patent/HRP20140964T1/hr unknown
- 2010-10-22 KR KR1020127010343A patent/KR101355417B1/ko active Active
- 2010-10-22 PL PL10773886T patent/PL2491005T3/pl unknown
- 2010-10-22 GE GEAP201012677A patent/GEP20146123B/en unknown
-
2012
- 2012-04-16 TN TNP2012000174A patent/TN2012000174A1/en unknown
- 2012-04-16 IL IL219217A patent/IL219217A0/en active IP Right Grant
- 2012-04-20 ZA ZA2012/02916A patent/ZA201202916B/en unknown
- 2012-04-20 CO CO12065428A patent/CO6531459A2/es unknown
- 2012-04-20 CL CL2012001010A patent/CL2012001010A1/es unknown
- 2012-04-23 CU CUP2012000065A patent/CU20120065A7/es active IP Right Grant
-
2014
- 2014-11-21 SM SM201400176T patent/SMT201400176B/xx unknown
-
2016
- 2016-01-27 US US15/007,543 patent/US9573882B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2596786T (lt) | Eikozapentaeno rūgšties etilo esterio naudojimas hipertriglicidemijai gydyti | |
| IL219613A (en) | For oral administration, for use in the treatment of dry mouth | |
| EP2378947A4 (en) | METHODS AND DEVICES FOR ENDOSCOPIC ACCESS TO THE HEART | |
| ZA201101303B (en) | Kit for the treatment of onychomycosis | |
| IL215856A0 (en) | Compositions and methods for treatment of cardiovascular disease | |
| SI2137141T1 (sl) | Arilamidi bifenil-4-il-sulfonske kisline in njihova uporaba kot terapevtska sredstva | |
| ZA201202916B (en) | Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease | |
| IL208236A0 (en) | Use of cathepsin c | |
| IL207247A0 (en) | Use of ranolazine for the treatment of cardiovascular disease | |
| GB0708452D0 (en) | Treatment of nuclear studge | |
| IL213711A0 (en) | Pharmaceuticl formulation of nanonised fenofibrate | |
| PL2307380T3 (pl) | Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego | |
| ZA201307847B (en) | 4-(haldalkyl)(dimethyl) ammonio) butandates and use thereof in the treatment of cardiovascular disease | |
| SI2588093T1 (sl) | Tapentadol za uporabo pri zdravljenju sindroma razdražljivega črevesja | |
| ZA201005770B (en) | The treatment of damaged skin | |
| EP2282747A4 (en) | USE OF ENTERIAN GLIA CELLS | |
| GB0716840D0 (en) | Treatment of cardiovascular disease | |
| GB0820562D0 (en) | Novel use and treatment | |
| GB0802904D0 (en) | Treatment of metabolic syndrome | |
| GB2473735B (en) | Skin treatment formulation | |
| GB0817859D0 (en) | Treatment of proteostatic disease | |
| GB0819543D0 (en) | Treatment of proteostatic disease | |
| GB0806696D0 (en) | Sunbed towel brace | |
| PL117824U1 (pl) | Oparcie pleców krzesłaOparcie pleców krzesła | |
| GB0819037D0 (en) | Skin treatment formulation |